HARBIN, China, Sept. 28 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company's 2010 Annual Meeting of Shareholders will be held on Tuesday, October 12, 2010 at the Company's headquarters at Songbei Development District, Harbin, China. The proxy materials and annual report on Form 10-K are available on the Company's website, www.cski.com.cn.

The time and venue of China Sky One Medical's Annual Meeting are as follows:

Date:   Tuesday, October 12, 2010

Time:   9:30 am (Beijing Time)

Venue:  No. 2158, North Xiang An Road, Song Bei District,

     Harbin, People's Republic of China 150028

As fully described in the Proxy Statement issued on September 16, 2010, at the annual meeting shareholders will be asked to:

1. Elect seven (7) directors for one year and until their successors have been duly elected and qualified; and
2. Transact such other business as may properly come before the Annual Meeting.

China Sky One Medical's executives will provide an investor presentation to discuss the Company's growth strategy, business outlook, and financial performance. The

Company's management and Board members will also accept questions from analysts and investors. For those unable to attend the annual meeting, a video record will be available on the Company's website from October 20, 2010.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's operation in the TCM herbal growing field. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

SOURCE China Sky One Medical, Inc.